Eric C. Klawiter, MD
Affiliations: | Neurology | Massachusetts General Hospital, Boston, MA |
Area:
multiple sclerosisGoogle:
"Eric Klawiter"Mean distance: 20.48 (cluster 46)
Parents
Sign in to add mentor| Anne Haney Cross | post-doc | 2008-2010 | Washington University School of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Herranz E, Treaba CA, Barletta VT, et al. (2024) Characterization of cortico-meningeal translocator protein expression in multiple sclerosis. Brain : a Journal of Neurology |
| Krijnen EA, Russo AW, Salim Karam E, et al. (2023) Detection of grey matter microstructural substrates of neurodegeneration in multiple sclerosis. Brain Communications. 5: fcad153 |
| Barletta VT, Herranz E, Treaba CA, et al. (2023) In vivo characterization of microglia and myelin relation in multiple sclerosis by combined C-PBR28 PET and synthetic MRI. Journal of Neurology |
| Krijnen EA, Ngamsombat C, George IC, et al. (2023) Axonal and myelin changes and their inter-relationship in the optic radiations in people with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9: 20552173221147620 |
| Russo AW, Stockel KE, Tobyne SM, et al. (2022) Associations between corpus callosum damage, clinical disability, and surface-based homologous inter-hemispheric connectivity in multiple sclerosis. Brain Structure & Function |
| Barletta V, Herranz E, Treaba CA, et al. (2021) Quantitative 7-Tesla Imaging of Cortical Myelin Changes in Early Multiple Sclerosis. Frontiers in Neurology. 12: 714820 |
| Fox RJ, Raska P, Barro C, et al. (2021) Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520986956 |
| Goodman AD, Fedler JK, Yankey J, et al. (2021) Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype. Annals of Clinical and Translational Neurology. 8: 111-118 |
| Naismith RT, Bermel RA, Coffey CS, et al. (2020) Effects of ibudilast on MRI measures in the phase 2 SPRINT-MS study. Neurology |
| Bermel RA, Fedler JK, Kaiser P, et al. (2020) Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520964409 |